We included prospective cohort studies and case–control studies with a baseline measure of PA and a follow-up measure of all-cause dementia, Alzheimer’s disease or vascular dementia. Only studies with ...

Case-control studies : design, conduct, analysis by Schlesselman, James J; Stolley, Paul D. Publication date 1982 Topics Epidemiology -- Statistical methods, Experimental design, Epidemiology ...

Background The current guidelines for aerobic activity require that adults carry out ≥150 min/week of moderate-intensity physical activity, with a large body of epidemiological evidence showing this ...

Background Microbiome dysbiosis predisposes to colorectal cancer (CRC), but a population-based study of oral antibiotic exposure and risk patterns is lacking. Objective To assess the association ...

ALBANY — New York’s highest court has upheld the city of Kingston’s vacancy study and subsequent decision to reduce rents in ...

Background Abundant, indirect epidemiological evidence indicates that influenza contributes to all-cause mortality and cardiovascular hospitalisations with studies showing increases in acute ...

The Bangladesh trial was done over 2 years and estimated 54% (95% CI 16–75) efficacy in the first year and 67% (43–81) in the second year after vaccination among those aged 5 years and older. 17 ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...

As a hobbyist woodworker for the last 25 years, I’ve accumulated a lot of tools. If you asked how many I have, I’d echo the quip gun owners often say: more than I need, but not as many as I want.

Our analysis reveals major infrastructure deficits in the Commonwealth, which could directly affect the availability of effective, efficient, equitable, and responsive screening, diagnosis, and ...

Study results demonstrated 76.9% of patients treated with rusfertide plus current standard of care achieved a clinical response, compared to 32.9% in the placebo plus ... three-fold reduction in the ...

The Phase 3 VERIFY study (NCT05210790) is an ongoing, three-part, global, randomized, placebo-controlled study evaluating rusfertide in 293 patients with polycythemia vera over a 156-week period.